First Quadrant L P CA grew its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 100.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,000 shares of the company’s stock after purchasing an additional 5,500 shares during the quarter. First Quadrant L P CA’s holdings in Henry Schein were worth $902,000 as of its most recent SEC filing.
Several other hedge funds have also recently made changes to their positions in the company. Leavell Investment Management Inc. raised its stake in shares of Henry Schein by 103.5% during the 3rd quarter. Leavell Investment Management Inc. now owns 29,028 shares of the company’s stock valued at $2,380,000 after purchasing an additional 14,764 shares during the period. Carroll Financial Associates Inc. raised its stake in shares of Henry Schein by 93.8% during the 3rd quarter. Carroll Financial Associates Inc. now owns 9,064 shares of the company’s stock valued at $739,000 after purchasing an additional 4,386 shares during the period. State of New Jersey Common Pension Fund D raised its stake in shares of Henry Schein by 100.0% during the 3rd quarter. State of New Jersey Common Pension Fund D now owns 100,000 shares of the company’s stock valued at $8,199,000 after purchasing an additional 50,000 shares during the period. Duncker Streett & Co. Inc. raised its stake in shares of Henry Schein by 102.1% during the 3rd quarter. Duncker Streett & Co. Inc. now owns 39,870 shares of the company’s stock valued at $3,268,000 after purchasing an additional 20,145 shares during the period. Finally, Korea Investment CORP raised its stake in shares of Henry Schein by 100.0% during the 3rd quarter. Korea Investment CORP now owns 64,096 shares of the company’s stock valued at $5,255,000 after purchasing an additional 32,048 shares during the period. 53.07% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities analysts have recently issued reports on HSIC shares. Credit Suisse Group reiterated a “hold” rating and issued a $87.50 price objective on shares of Henry Schein in a report on Tuesday, August 29th. Piper Jaffray Companies upgraded Henry Schein from a “neutral” rating to an “overweight” rating in a report on Friday, September 15th. Morgan Stanley initiated coverage on Henry Schein in a report on Thursday, September 21st. They set an “equal weight” rating and a $88.00 target price for the company. UBS AG restated a “buy” rating on shares of Henry Schein in a report on Friday, September 15th. Finally, Stifel Nicolaus reiterated a “hold” rating and issued a $89.00 price objective on shares of Henry Schein in a report on Thursday, October 19th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $89.88.
TRADEMARK VIOLATION WARNING: “Henry Schein, Inc. (HSIC) Stake Raised by First Quadrant L P CA” was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://ledgergazette.com/2017/11/13/henry-schein-inc-hsic-shares-bought-by-first-quadrant-l-p-ca.html.
In other news, SVP Paul Rose sold 2,126 shares of Henry Schein stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the sale, the senior vice president now directly owns 17,841 shares of the company’s stock, valued at approximately $3,077,750.91. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 1.19% of the stock is owned by company insiders.
Shares of Henry Schein, Inc. (NASDAQ HSIC) traded down $2.61 during mid-day trading on Monday, hitting $67.05. The stock had a trading volume of 5,071,400 shares, compared to its average volume of 1,106,182. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.86 and a current ratio of 1.55. Henry Schein, Inc. has a 1-year low of $67.02 and a 1-year high of $93.50. The firm has a market capitalization of $10,523.79, a P/E ratio of 18.81, a PEG ratio of 1.89 and a beta of 1.03.
Henry Schein (NASDAQ:HSIC) last posted its earnings results on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.90 by ($0.03). The firm had revenue of $3.16 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The company’s revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.84 earnings per share. sell-side analysts forecast that Henry Schein, Inc. will post 3.6 earnings per share for the current year.
Henry Schein announced that its Board of Directors has initiated a stock repurchase plan on Monday, September 18th that allows the company to repurchase $400.00 million in outstanding shares. This repurchase authorization allows the company to buy up to 6.3% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s board of directors believes its shares are undervalued.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.